Hematological Malignancies

• CLINICAL_TRIALS trial_result · 2015-03-03
  Clinical Trial Update: A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area [Phase 4]

  A Phase 4 trial reports a body surface area–based dosing regimen for posaconazole prophylaxis in children with hematological malignancies.

• CLINICAL_TRIALS trial_result · 2015-01-15
  Clinical Trial Update: Reduced Intensity Haploidentical Transplant for Hematological Malignancies [Phase 1, Phase 2]

  This clinical trial update presents results from Phase 1 and Phase 2 studies of reduced-intensity haploidentical transplantation for hematol…

• CLINICAL_TRIALS trial_result · 2014-05-12
  Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies [Phase 1]

  Phase 1 study of obatoclax mesylate (GX15-070MS) in hematological malignancies has completed. The update discusses safety and preliminary ef…

• CLINICAL_TRIALS trial_result · 2014-02-20
  Clinical Trial Update: Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD) [Phase 2]

  Phase 2 trial update on thymoglobulin, sirolimus, and mycophenolate mofetil for preventing acute GVHD in hematologic malignancies; study ter…

• CLINICAL_TRIALS trial_result · 2013-03-29
  Clinical Trial Update: Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients [Phase 3]

  A Phase 3 trial evaluating whether concentrated citrate locking reduces central venous catheter-related complications in hematological patie…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2009-02-06
  Clinical Trial Update: Intrabone Cord Blood Transplantation [Phase 4]

  A Phase 4 clinical trial update for intrabone cord blood transplantation in hematological malignancies, with the trial status currently unkn…